ConductScience.org, home
SW620
API referenceFor AI assistants

Cell line · CVCL_0547

Papers239

1 more article gives this line's RRID in its Methods without naming the line nearby, so it is not listed.

1 to 20 of 239

Download this page as JSON
PaperJournalYearHow we knowRetractedSource
IFNAR1 stabilization sustains CD8+ T cell persistence in IFN-high colorectal cancer liver metastases.Sci Adv2026Its Methods give the RRID and name the linePubMed
MZF1 Inhibits TGFβ-1/SMAD Signaling by Transcriptionally Activating SnoN to Augment Tumorigenic Potential in Colon Cancer.Adv Sci (Weinh)2026Its Methods give the RRID and name the linePubMed
MIIP Inhibits Colorectal Cancer Progression by Modulating Neutrophils Infiltration and Neutrophil Extracellular Trap Formation.Adv Sci (Weinh)2026Its Methods give the RRID and name the linePubMed
Targeting O6-methylguanine-DNA Methyltransferase Deficiency in Preclinical Models of Extracranial Human Cancers with a Tumor-Selective DNA-Modifying Agent.Mol Cancer Ther2026Its Methods give the RRID and name the linePubMed
Bridging the gap: a genetically validated avian chorioallantoic membrane platform for investigation of spontaneous circulating tumor cells.Mol Oncol2026Its Methods give the RRID and name the linePubMed
Intratumoral Bacillus regulating colorectal cancer liver metastasis: links to lipid metabolism and APOE+ macrophages.Front Immunol2026Its Methods give the RRID and name the linePubMed
The Mechanism Underlying Inhibition of Colorectal Cancer Invasion by Quxie Capsule Through CRK-RAC Signaling Pathway Regulation.Integr Cancer Ther2026Its Methods give the RRID and name the linePubMed
Slap restricts oncogenic Src-family kinase signaling to maintain colonic epithelial homeostasis.Elife2026Its Methods give the RRID and name the linePubMed
CDK8/19 inhibition prevents adaptive resistance to CDK4/6 inhibitors in vitro and in vivo.Cell Rep Med2026Its Methods give the RRID and name the linePubMed
Selenium Nanoparticles Selectively Target KRAS G13D to Inhibit Colorectal Cancer.Adv Sci (Weinh)2026Its Methods give the RRID and name the linePubMed
Preclinical Characterization of CLSP-1025, a First-in-Class, Mutation-Specific T-Cell Engager Targeting a Neoantigen Derived from a Common p53 Mutation.Clin Cancer Res2026Its Methods give the RRID and name the linePubMed
CRISPR Screening Identifies SMARCAL1 and MRN as Modulators of WRN Dependency in MSI-H Colorectal Cancer.Cancer Res2026Its Methods give the RRID and name the linePubMed
A Tale of Two Cell Lines: Characterization of Differential Efficacy of Small Molecule Drugs Cediranib and NU-7441 on Primary Versus Metastatic Colorectal Cancer.Pharmacol Res Perspect2026Its Methods give the RRID and name the linePubMed
MLKL confers ferroptosis resistance in colorectal cancer cells via impaired ESCRT-III-mediated membrane repair.Biol Direct2026Its Methods give the RRID and name the linePubMed
HP1γ promotes the progression of colorectal cancer through interaction with RBPJ of the Notch signaling pathway.Cell Biol Toxicol2026Its Methods give the RRID and name the linePubMed
Beta-site Amyloid Precursor Protein Cleaving Enzyme 1 Overexpression Abrogates ST6GAL1 Mediated Rectal Cancer Chemoradiation Resistance.Cancer Genomics Proteomics2026Its Methods give the RRID and name the linePubMed
Repurposing Artesunate to Combat Progression and Metastasis via Targeting Circulating Tumor Cells.Oncol Res2026Its Methods give the RRID and name the linePubMed
A whole genomic CRISPR-Cas9 screen identifies the amino acid transporter SLC43A1 (LAT3) as a major determinant of oxaliplatin sensitivity in colorectal cancer cells.Mol Cancer Ther2026Its Methods give the RRID and name the linePubMed
Non-Temperature-Induced Antitumor Effects of Amplitude-Modulated Radiofrequency: Molecular and Functional Synergies with Radiotherapy.Cancers (Basel)2026Its Methods give the RRID and name the linePubMed
Viral mimicry redirects immunosuppressed colorectal tumour landscapes towards a proinflammatory and CMS1-like regenerative state.Commun Biol2026Its Methods give the RRID and name the linePubMed

cell-lines-2026-11-14-0.1.0

Next page

Sources 4

  • CellosaurusCC BY 4.0, with credit to Cellosaurus (SIB)
  • PubMed Central's articlesTitles shown only for CC0, CC BY and public domain articles
  • NLM's PMC Article DatasetsCourtesy of NLM, which does not endorse this database
  • PubMedNLM's terms
Each source's terms
  • CellosaurusCC BY 4.0. Cellosaurus's README: "we have chosen to apply the Creative Commons Attribution 4.0 International (CC BY 4.0) license to Cellosaurus (https://creativecommons.org/licenses/by/4.0/). This means that you are free to copy and redistribute Cellosaurus in any medium or format. You can remix, transform, and build upon Cellosaurus for any purpose, even commercially. You must give appropriate credit, provide a link to the license, and indicate if changes were made." Copyright (c) CALIPHO group, SIB Swiss Institute of Bioinformatics. Read on 14 Nov 2026 at https://ftp.expasy.org/databases/cellosaurus/README
  • PubMed Central's articlesEach article's own license. Its words show only under CC0, CC BY or public domain
  • NLM's PMC Article DatasetsNLM's PMC Article Datasets on AWS, https://registry.opendata.aws/ncbi-pmc. Its terms: users "acknowledge NLM as the source of the data in a clear and conspicuous manner", do not use the PubMed Central wordmark or the PMC logo, do not "indicate or imply that NLM/NIH/HHS has endorsed" a product, and "only distribute data that are licensed for redistribution". Each article keeps its own license: https://pmc.ncbi.nlm.nih.gov/about/copyright/
  • PubMedNLM's terms

Cellosaurus, SIB Swiss Institute of Bioinformatics, https://www.cellosaurus.org, CC BY 4.0. Its problem notes are given in its own words.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/cell-lines/v1/CVCL_0547/papers

API referenceFor AI assistants